← Eichor
Condition: Refractory Angina Pectoris Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Refractory Angina Pectoris

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Use of the Neovasc Coronary Sinus Reducer System for the Treatment of Refractory Angina Pectoris in Patients With Ngina
NA · 2 location(s) · Tel-Aviv Sourasky Medical Center · NCT01566175COSIMA: COronary SInus Reducer for the Treatment of Refractory Microvascular Angina
NA · 1 location(s) · Johannes Gutenberg University Mainz · NCT04606459Investigational Trial to Evaluate XC001 Delivered Via an Cardiac Catheter in Subjects With Chronic Angina.
Phase 2 · 1 location(s) · XyloCor Therapeutics, Inc. · NCT07048808Efficacy of the COronary SInus Reducer in Patients With Refractory Angina II
NA · 95 location(s) · Shockwave Medical, Inc. · NCT05102019VasoStar Vibrational Guidewire System to Facilitate Crossing Coronary Artery Chronic Total Occlusions
NA · 2 location(s) · VasoStar, LLC · NCT06193954Assessing the Safety and Effectiveness of Intracoronary Stem Cells in Patients With Refractory Angina
Phase 2 · 1 location(s) · Barts & The London NHS Trust · NCT05711849Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microva
NA · 1 location(s) · Imperial College London · NCT05492110Lower Silesia Sinus Reducer Registry
Phase N/A · 2 location(s) · Regional Cardiology Center, The Copper Health Centre (MCZ), · NCT06288165
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.